Go Pro
→ Feds Say Your Cash Isn’t Property—Can They Take It? (From Priority Gold) (Ad)tc pixel
OTCMKTS:HYPMY

Hypermarcas Q1 2025 Earnings Report

Hypermarcas logo
$4.51 -0.04 (-0.82%)
As of 10:08 AM Eastern
ProfileEarnings HistoryForecast

Hypermarcas EPS Results

Actual EPS
-$0.04
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Hypermarcas Revenue Results

Actual Revenue
$184.34 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Hypermarcas Announcement Details

Quarter
Q1 2025
Date
4/23/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Hypermarcas' next earnings date is estimated for Wednesday, November 11, 2026, based on past reporting schedules.

Conference Call Resources

Hypermarcas Earnings Headlines

Hypera S.A. (HYPMY) Q2 2026 Earnings Call Transcript
August 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4934927-hypera-s-a-hypmy-q2-2026-earnings-call-transcript
Hypera SA ADR (HYPMY)
May 24, 2026  |  investing.comhttps://www.investing.com/equities/hypermarcas-sa-financial-summary
This Gold Explorer Is Approaching Its Biggest Milestone Yet
A little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.25 g/t. After roughly 21,000 metres of drilling, the company is closing in on its first-ever mineral resource estimate, expected in Q3 or Q4 2026. That estimate could offer the market its first real look at the scale of this emerging gold system.tc pixel
September 16 at 1:00 AM  |  Wall Street Logic (Ad)
Hypera S.A. (HYPMY) Q3 2025 Earnings Call Transcript
October 29, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4834950-hypera-s-a-hypmy-q3-2025-earnings-call-transcript
Brazil's Hypera announces new majority stakeholder group
July 7, 2025  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/brazils-hypera-announces-new-majority-stakeholder-group-2025-07-07/
Hypera S.A. (HYPMY) Stock Price, Quote, News & Analysis - Seeking Alpha
June 29, 2025  |  seekingalpha.comhttps://seekingalpha.com/symbol/HYPMY
See More Hypermarcas Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hypermarcas? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hypermarcas and other key companies, straight to your email.

About Hypermarcas

Hypermarcas (OTCMKTS:HYPMY) S.A. was a Brazilian consumer health and pharmaceutical company that developed, manufactured and marketed branded products for healthcare, personal care and consumer markets. Its portfolio historically included over-the-counter medicines, prescription products, vitamins, toiletries, cosmetics and other household or personal-care brands.

The company expanded through acquisitions and operated primarily in Brazil, building a broad portfolio of locally recognized brands. In the mid-2010s, Hypermarcas began divesting its non-pharmaceutical businesses to concentrate on healthcare and medicines. In 2018, it changed its corporate name to Hypera S.A. and adopted the Hypera Pharma brand.

Under the Hypera Pharma name, the business has focused on prescription medicines, branded generics, over-the-counter treatments and consumer healthcare products, serving the Brazilian market through pharmacies, hospitals and other distribution channels. Hypermarcas is therefore principally a historical name associated with the company now known as Hypera Pharma.

View Hypermarcas Profile
Earnings Tools